Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram

Neuropsychobiology

Volumn 52, Issue 3, 2005, Pages 155-162

  Choi, Myoung Jin ^a   Kang, Rhee Hun ^a   Ham, Byung Joo ^b   Jeong, Han Yong ^c   Lee, Min Soo ^a,d  

^a Korea University   (South Korea)

^b Hankang Sacred Heart Hospital   (South Korea)

^c Soonchunhyang University College of Medicine   (South Korea)

^d Department of Neuropsychiatry ^*  (South Korea)

Author keywords

5 HTR2A promoter polymorphism; Antidepressant; Citalopram; Major depressive disorder; Treatment response

Indexed keywords

CITALOPRAM; SEROTONIN 2A RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG EFFICACY; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

ALLELES; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DNA; FEMALE; HETEROZYGOTE; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RECEPTOR, SEROTONIN, 5-HT2A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN UPTAKE INHIBITORS;

EID: 24944471356     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087847     Document Type: Article

References (50)

1. Arora RC, Meltzer HY: Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 1989;146:730-736.
2. Yates M, Leake A, Candy JM, Fairbairm AF, McKeith IG, Ferrier IN: 5HT2 receptor changes in major depression. Biol Psychiatry 1990;27:489-496.
3. Skrebuhhova T, Allikmets L, Matto V: 5-HT2A receptors mediate the effects of antidepressants in the elevated plus-maze test but have a partial role in the forced swim test. Med Sci Res 1999;27:277-280.
4. 18F]setoperone PET imaging study. Am J Psychiatry 2001;158:78-86.
5. Yatham LN, Liddle PF, Dennie J: Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labled setoperone. Arch Gen Psychiatry 1999;56:705-711.
6. Du L, Bakish D, Lapierre YD, Ravindran AV, Hrdina PD: Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet 2000;7:56-60.
7. Glennon RA, Dukat M: Serotonin receptor subtypes; in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, 1995, vol 45, pp 1125-1131.
8. Maj J, Bijak M, Dziedzicka-Wasylewska M, Rogoz R, Rogoz Z, Skuza G, Okarski T: The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain. Psychopharmacology (Berl) 1996;127:73-82.
9. Chen K, Yang W, Grimsby J, Shih JC: The human 5HT2A receptor is encoded by a multiple intron-exon gene. Brain Res Mol Brain Res 1992;14:20-26.
10. Erdmann J, Shimron-Abarbanell D, Rietschel M: Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet 1996;97:614-619.
11. Spurlock G, Heils A, Holmans P, Williams J, D'Souza UM, Cardno A, et al: A family-based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol Psychiatry 1998;3:42-49.
12. Arranz MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, Kirov G, Collier DA, Kerwin RW: Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatry 1998;3:61-66.
13. Chee IS, Lee SW, Kim JL, Wang SK, Shin YO, Shin SC, Lee YH, Hwang HM, Lim MR: 5-HT2A receptor gene promoter polymorphism -1438A/G and bipolar disorder. Psychiatr Genet 2001;11:111-114.
14. Enoch MA, Goldman D, Barnett R, Sher L, Mazzanti CM, Rosenthal NE: Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A. Mol Psychiatry 1999;4:89-92.
15. Enoch MA, Kaye WH, Rotondo A, Greenberg BD, Murphy DL, Goldman D: 5-HT2A promoter polymorphism -1438A/G, anorexia nervosa and obsessive-compulsive disorder. Lancet 1998;351:1785-1786.
16. Bonnier B, Gorwood P, Hamon M, Sarfati Y, Boni C, Hardy-Bayle MC: Association of 5-HT(2A) receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk. Biol Psychiatry 2002;51:762-765.
17. Choi MJ, Lee HJ, Lee HJ, Ham BJ, Cha JH, Ryu SH, Lee MS: Association between major depressive disorder and the -1438A/G polymorphism of the serotonin 2A receptor gene. Neuropsychobiology 2004;49:38-41.
18. Arranz M, Collier D, Sodhi M, Ball D, Roberts G, Price J, Sham P, Kerwin R: Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 1995;346:281-282.
19. Lane HY, Chang YC, Chiu CC, Chen ML, Hsieh MH, Chang WH: Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene. Am J Psychiatry 2000;159:1593-1595.
20. Cusin C, Serretti A, Zanardi R, Lattuada E, Rossini D, Lilli R, Lorenzi C, Smeraldi E: Influence of monoamine oxydase A and serotonin receptor 2A polymorphisms in SSRIs antidepressant activity. Int J Neuropsychopharmacol 2002;5:27-35.
21. Minov C, Baghai TC, Schule C, Zwanzger P, Schwarz MJ, Zill P, Rupprecht R, Bondy B: Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett 2001;303:119-122.
22. Sato K, Yoshida K, Takahashi H, Ito K, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K: Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder. Neuropsychobiology 2002;46:136-140.
23. Baumann P: Pharmacology and pharmacokinetics of citalopram and other SSRIs. Int Clin Psychopharmacol 1996;11(suppl 1):5-11.
24. Baumann P, Rochat B: Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror. Int Clin Psychopharmacol 1995;10(suppl 1):15-21.
25. Serretti A, Lorenzi C, Cusin C, Zanardi R, Lattuada E, Rossini D, Lilli R, Pirovano A, Catalano M, Smeraldi E: SSRIs antidepressant activity is influenced by G beta 3 variants. Eur Neuropsychopharmacol 2003;13:117-122.
26. Rothman KJ: No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-46.
27. Buchner A, Faul F, Erdfelder E: G-Power: A priori, post-hoc, and Compromise Power Analyses for the Macintosh (Version 2.1.1) [Computer Program]. Trier, University of Trier, 1996.
28. Burnet PW, Eastwood SL, Lacey K, Harrison PJ: The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain. Brain Res 1995;675:157-168.
29. Saltzman AG, Morse B, Whiteman MM, Ivanshchenko Y, Jaye M, Felder S: Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. Biochem Biophys Res Commun 1991;181:1469-1478.
30. Sparkes RS, Lan N, Klisak I, Mohanda T, Diep A, Kojis T: Assignment of a serotonin 5HT-2 receptor gene to human chromosome 13q14-q21 and mouse chromosome 14. Genomics 1991;9:461-465.
31. Zhu Q-S, Chen K, Shih JC: Characterization of the human 5-HT2A receptor gene promoter. J Neurosci 1995;15:4885-4895.
32. Shih JC, Zhu Q, Chen K: Determination of transcription initiation sites and promoter activity of the human 5-HT2A receptor gene. Behav Brain Res 1996;73:59-62.
33. Ding G, Toth M, Zhou Y, Parks C, Hoffman BJ, Shenk T: Glial cell-specific expression of the serotonin 2 receptor gene: selective reactivation of a repressed promoter. Brain Res Mol Brain Res 1993;20:181-191.
34. Du YL, Wilcox BD, Teitler M, Jeffery JJ: Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter constitutive and inducible activity in myometrial smooth muscle cells. Mol Pharmacol 1994;45:1125-1131.
35. Bondy B, Kuznik J, Baghai T, Schule C, Zwanzger P, Minov C, Rupprecht R, Meyer H, Engel R, Eisenmenger W, Ackenheil M: Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. Am J Med Genet 2000;96:831-835.
36. Tut T, Wang J, Lim C: Negative association between T102C polymorphism at the 5-HT2A receptor gene and bipolar affective disorders in Singaporean Chinese. J Affect Disord 2000;58:211-214.
37. Ziegler A, Hebebrand J, Gorg T, Rosenkranz K, Fichter M, Herpertz-Dahlmann B, Remschmidt H, Hinney A: Further lack of association between the 5-HT2A gene promoter polymorphism and susceptibility to eat ingdisorders and a meta-analysis pertaining to anorexia nervosa. Mol Psychiatry 1999;4:410-412.
38. Nierenberg AA, Wright EC: Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry 1999;60 (suppl 22):7-11.
39. Inada Y, Yoneda H, Koh J, Sakai J, Himei A, Kinoshita Y, Akabame K, Hiraoka Y, Sakai T: Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Res 2003;118:25-31.
40. Tot S, Erdal ME, Yazici K, Yazici AE, Metin O: T102C and -1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder. Eur Psychiatry 2003;18:249-254.
41. Walitza S, Wewetzer C, Warnke A, Gerlach M, Geller F, Gerber G, Gorg T, Herpertz-Dahlmann B, Schulz E, Remschmidt H, Hebebrand J, Hinney A: 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders. Mol Psychiatry 2002;7:1054-1057.
42. Zohar J, Westenberg HG: Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 2000;403:39-49.
43. Connie S, John H: Comparison of the effect of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 1999;19:467-489.
44. Du Y-L, Wilcox ED, Jeffrey JJ: Regulation of rat 5-hydroxytryptamine type 2A receptor gene activity: identification of cis elements that medicate basal and 5- hydroxytryptamine-dependent gene activation. Mol Pharmacol 1995;47:915-922.
45. Parsons MJ, D'Souza UM, Arranz MJ, Kerwin RW, Markoff AJ: The -1438A/G polymorphism in the 5-hydroxytryptanmine type 2A receptor gene affects promoter activity. Biol Psychiatry 2004;56:406-410.
46. Arias B, Catalan R, Gasto C, Gutierrez B, Fananas L: 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow-up study. J Clin Psychopharmacol 2003;23:563-567.
47. Stahl SM: Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Biol Psychiatry 2000;48:894-901.
48. Mendels J, Kiev A, Fabre LF: Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia. Depress Anxiety 1999;9:54-60.
49. Gorwood P: Genetic association studies in behavioral neuroscience; in Cruzio W, Gerlai R (eds): Molecular Genetic Techniques for Behavioral Neuroscience. Amsterdam, Elsevier, 1999, pp 113-121.
50. Kim JW: Association study and the population admixture; in Korean Society of Biological Psychiatry (ed): Human Neurobehavioral Genetics in the 21st Century. Seoul, Winter Workshop, 2003.